Announcements
Sidley Represents ZAP Surgical as It Secures US$36 Million in Financing
October 22, 2026
Sidley represented ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, in connection with US$36 million in financing, led by Catalio Capital Management, a healthcare and AI-focused investment firm, with continued support from Baheal, ZAP’s strategic partner in China. The financing will support ZAP’s continued growth and commercialization of its innovative technology for non-invasive robotic therapeutics in neuroscience.
More information about the transaction is available here.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital) and Elizabeth Tabas Carson (Global Finance), and included Reid McKinney and Thomas Power (Global Finance).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Aquestive Therapeutics in Exclusive U.S. Licensing Agreement With Eton PharmaceuticalsOctober 16, 2026Sidley Represents Nous Research in US$90 Million Series B FinancingOctober 12, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Represents Jiangsu Nhwa Pharmaceutical in Its US$517.5 Million Licensing Transaction With SomniveraSeptember 30, 2026Sidley Represents Bluevine in Its US$340 Million Acquisition by Valley National BankSeptember 28, 2026Sidley Represents Star51 Capital in Its Investment in UltraSight’s US$24 Million FinancingSeptember 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory